-
Christoph Varenhorst, Stefan James, David Erlinge, John T. Brandt, Oscar Ö. Braun, Michael Man, Agneta Siegbahn, Joseph Walker, Lars Wallentin, Kenneth J. Winters, and Sandra L. Close
-
Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease
European Heart Journal Advance Access published on May 9, 2009
Eur Heart J 2009 30: 1744-1752; doi:10.1093/eurheartj/ehp157
[Abstract]
[FREE Full Text]
[PDF]
[Supplementary Data]
OPEN ACCESS
|